Back to search

Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma

Data up to Jan 2025

Published1983
Citations17
References15

Total Citations Per Year

Abstract

References (15)

PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS

1972 • 1,130 citations

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors

1973 • 184 citations

Etoposide (VP-16-213)

1979 • 151 citations

The podophyllotoxin derivatives VP16-213 and VM26

1982 • 146 citations

Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.

1975 • 133 citations

Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer

1982 • 107 citations

Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213.

1976 • 102 citations

Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.

1976 • 102 citations

Podophyllotoxin derivative VP 16-213

1979 • 86 citations

A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry

1981 • 48 citations

VP16-213 and podophyllotoxin

1982 • 44 citations

In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma

1982 • 29 citations

DNA content distribution of in vivo and in vitro lines of Lewis lung carcinoma

1982 • 13 citations

Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia

1982 • 13 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung… (1983) – Cancer Chemotherapy and Pharmacology | Metascience Observatory Explorer